PARIS — Partnering with Fight for Sight, the European Society of Retina Specialists will award a 2 million euros grant to a research project addressing the best treatment option for submacular hemorrhage secondary to wet age-related macular degeneration.
In a randomized trial, surgical management involving vitrectomy, subretinal injection of tissue plasminogen activator and intravitreal gas injection of SF6 will be compared with anti-VEGF monotherapy with Eylea (aflibercept, Regeneron/Bayer).
The surgery aims at dissolving and then mechanically displacing the submacular hemorrhage.
“There
Uncategorized